Jennifer E. Naylor
Director of Research Administration
Also affiliated: United States Food and Drug Administration (2017–2019); University of Mississippi Medical Center (2014–2016)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Jennifer E. Naylor's research focuses on behavioral and pharmacological studies, particularly concerning drug self-administration and the dose-response relationships of various substances in animal models. Her work investigates the reinforcing effects of drugs, including opioids and central nervous system stimulants like cocaine, and explores the underlying mechanisms in the central nervous system. Naylor has published on topics related to substance abuse and its consequences, with a recent publication in 2021 addressing a medical case of cerebral venous thrombosis. Her research network includes collaborators at the University of Arkansas for Medical Sciences, such as Gerry Ezell, Ramya Bachu, and Tanvi H Patel, with whom she shares co-authored publications. Naylor's scholarly contributions are reflected in her h-index of 7 and 313 total citations across 11 publications.
Metrics
- h-index: 7
- Publications: 11
- Citations: 312
Positions
-
Director of Research Administration publications 2020–2021University of Arkansas for Medical Sciences Institution web page
Selected Publications
-
Cerebral Venous Thrombosis Presenting as a Subacute Headache in a Young Man With Undiagnosed Factor V Leiden Mutation (2021)
-
Kappa opioid agonists reduce oxycodone self-administration in male rhesus monkeys (2020)
-
Use of a physiologically-based pharmacokinetic model to explore the potential disparity in nicotine disposition between adult and adolescent nonhuman primates (2019)
-
Positron emission tomography (PET) imaging of nicotine-induced dopamine release in squirrel monkeys using [18F]Fallypride (2017)
-
Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats (2017)
Collaboration Network
Top Collaborators
- Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats
- Kappa opioid agonists reduce oxycodone self-administration in male rhesus monkeys
- Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats
- Kappa opioid agonists reduce oxycodone self-administration in male rhesus monkeys
- Positron emission tomography (PET) imaging of nicotine-induced dopamine release in squirrel monkeys using [18F]Fallypride
- Use of a physiologically-based pharmacokinetic model to explore the potential disparity in nicotine disposition between adult and adolescent nonhuman primates
- Positron emission tomography (PET) imaging of nicotine-induced dopamine release in squirrel monkeys using [18F]Fallypride
- Use of a physiologically-based pharmacokinetic model to explore the potential disparity in nicotine disposition between adult and adolescent nonhuman primates
- Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats
- Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats
- Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats
- Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats
- Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats
- Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats
- Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats
- Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats
- Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats
- Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats
- Positron emission tomography (PET) imaging of nicotine-induced dopamine release in squirrel monkeys using [18F]Fallypride
Similar Researchers
Based on overlapping research topics